1. Homepage
  2. Equities
  3. Israel
  4. TEL AVIV STOCK EXCHANGE
  5. ICL Group Ltd
  6. News
  7. Summary
    ICL   IL0002810146

ICL GROUP LTD

(ICL)
  Report
End-of-day quote TEL AVIV STOCK EXCHANGE  -  2022-08-15
32.89 ILS   +1.11%
05:33pICL Group to Work With Evogene's Lavie Bio Unit to Develop Novel Bio-Stimulant Products
MT
04:31pICL and Lavie Bio Enter Strategic Collaboration to Develop Novel Bio-Stimulant Products
BU
08/11ICL : Other Report or Announcement
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Icl Group Ltd Announces Appointment of Ms. Michal Silverberg to Its Board of Directors

06/29/2022 | 04:07pm EDT

ICL Group Ltd. announced that its Board of Directors appointed Ms. Michal Silverberg to the Company's Board of Directors, effective as of July 1, 2022, to serve until the next annual general meeting of shareholders of the Company. Michal Silverberg serves as a Managing Director at the Novartis Venture Fund (“NVF”) since 2017. Prior to joining NVF and from 2014, Ms. Silverberg served as a Senior Partner at Takeda Ventures and, prior to that and from 2007, Ms. Silverberg worked at Novo Nordisk in roles of increasing responsibility, including as Senior Director Business Development and New Product Commercialization, serving as a member of the BioPharm leadership team. Since 1998, Ms. Silverberg has held positions in various sectors of the life science industry, including in the Office of the Chief Scientist of Israel (the incubator program), venture capital (Ofer Brothers Hi Tech investing group) and global pharmaceutical and biotech companies, including various positions at MGVS Ltd., an Israeli biotech company, and at OSI Pharmaceuticals Inc. in a business development role. Ms. Silverberg currently serves as a director in several private companies. Ms. Silverberg holds a B.A. degree in economics and business management from Haifa University, Israel, an M.B.A. degree from Tel-Aviv University, Israel, and a M.A. degree in Biotechnology from Columbia University, New York.


© S&P Capital IQ 2022
All news about ICL GROUP LTD
05:33pICL Group to Work With Evogene's Lavie Bio Unit to Develop Novel Bio-Stimulant Products
MT
04:31pICL and Lavie Bio Enter Strategic Collaboration to Develop Novel Bio-Stimulant Products
BU
08/11ICL : Other Report or Announcement
PU
08/11ICL Group Ltd Signs Binding Memorandum of Understanding with A European Customer, to Su..
CI
08/03ICL to Participate in Fireside Chat at Jefferies Industrials Conference
BU
07/28BMO Capital Adjusts Price Target on ICL Group to $11 From $12, Maintains Market Perform..
MT
07/27TRANSCRIPT : ICL Group Ltd, Q2 2022 Earnings Call, Jul 27, 2022
CI
07/27ICL : INCORPORATION BY REFERENCE - Form 6-K
PU
07/27ICL Group Ltd Declare A Cash Dividend, Payable on September 14, 2022
CI
07/27ICL GROUP : Q2 Earnings Snapshot
AQ
More news
Analyst Recommendations on ICL GROUP LTD
More recommendations
Financials (USD)
Sales 2022 10 499 M - -
Net income 2022 2 257 M - -
Net Debt 2022 1 865 M - -
P/E ratio 2022 5,77x
Yield 2022 9,05%
Capitalization 12 987 M 12 987 M -
EV / Sales 2022 1,41x
EV / Sales 2023 1,59x
Nbr of Employees 12 000
Free-Float 53,2%
Chart ICL GROUP LTD
Duration : Period :
ICL Group Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ICL GROUP LTD
Short TermMid-TermLong Term
TrendsNeutralBearishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Last Close Price 10,09 $
Average target price 10,52 $
Spread / Average Target 4,21%
EPS Revisions
Managers and Directors
Raviv Zoller President & Chief Executive Officer
Aviram Lahav Chief Financial Officer
Yoav Doppelt Executive Chairman
Miri Mishor Executive Vice President-Information Technology
Anantha N. Desikan Chief Research, Development & Innovation Officer
Sector and Competitors
1st jan.Capi. (M$)
ICL GROUP LTD9.60%12 780
SOCIEDAD QUÍMICA Y MINERA DE CHILE S.A.120.92%31 823
PHOSAGRO35.93%16 716
YUNNAN YUNTIANHUA CO., LTD.38.23%7 579
UPL LIMITED5.54%7 443
PI INDUSTRIES LIMITED11.75%6 386